SE457959B - Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta - Google Patents

Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta

Info

Publication number
SE457959B
SE457959B SE8400098A SE8400098A SE457959B SE 457959 B SE457959 B SE 457959B SE 8400098 A SE8400098 A SE 8400098A SE 8400098 A SE8400098 A SE 8400098A SE 457959 B SE457959 B SE 457959B
Authority
SE
Sweden
Prior art keywords
resinate
formula
resin
active substance
acid
Prior art date
Application number
SE8400098A
Other languages
English (en)
Swedish (sv)
Other versions
SE8400098L (sv
SE8400098D0 (sv
Inventor
S C Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8400098D0 publication Critical patent/SE8400098D0/xx
Publication of SE8400098L publication Critical patent/SE8400098L/xx
Publication of SE457959B publication Critical patent/SE457959B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8400098A 1983-01-12 1984-01-10 Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta SE457959B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (es) 1983-01-12 1983-01-12

Publications (3)

Publication Number Publication Date
SE8400098D0 SE8400098D0 (sv) 1984-01-10
SE8400098L SE8400098L (sv) 1984-07-13
SE457959B true SE457959B (sv) 1989-02-13

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400098A SE457959B (sv) 1983-01-12 1984-01-10 Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta

Country Status (41)

Country Link
US (1) US4510128A (es)
EP (1) EP0122219B1 (es)
JP (1) JPS59134759A (es)
KR (1) KR900006747B1 (es)
AR (1) AR240310A1 (es)
AT (2) AT391467B (es)
AU (1) AU570230B2 (es)
BE (1) BE898649A (es)
CA (1) CA1218077A (es)
CH (1) CH655507B (es)
CS (1) CS269954B2 (es)
DD (1) DD218373A5 (es)
DE (2) DE3474152D1 (es)
DK (1) DK166683B1 (es)
DZ (1) DZ593A1 (es)
EG (1) EG16562A (es)
ES (1) ES8504849A1 (es)
FI (1) FI82682C (es)
FR (1) FR2542735B1 (es)
GB (1) GB2134529B (es)
GR (1) GR79793B (es)
HK (1) HK90390A (es)
HU (1) HU190750B (es)
IE (1) IE56545B1 (es)
IL (1) IL70660A (es)
IT (1) IT1177501B (es)
LU (1) LU85171A1 (es)
MA (1) MA20000A1 (es)
MC (1) MC1564A1 (es)
MT (1) MTP943B (es)
NL (1) NL8400098A (es)
NO (1) NO162862C (es)
NZ (1) NZ206815A (es)
OA (1) OA07628A (es)
PH (1) PH21795A (es)
PL (1) PL142737B1 (es)
PT (1) PT77932B (es)
RO (1) RO88481A (es)
SE (1) SE457959B (es)
ZA (1) ZA84212B (es)
ZW (1) ZW484A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
CH675537A5 (es) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
DE58903964D1 (de) * 1988-11-10 1993-05-06 Ciba Geigy Ag Fluessige orale formulierung.
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
EP0592569A1 (en) * 1991-07-03 1994-04-20 Sano Corporation Composition and method for transdermal delivery of diclofenac
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
JP5479086B2 (ja) 2006-03-16 2014-04-23 トリス・フアルマ・インコーポレーテツド 薬剤−イオン交換樹脂複合体を含有する放出調節製剤
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
CN102227244A (zh) * 2008-10-02 2011-10-26 匹兹堡大学-属高等教育联邦体系 用于治疗全身性炎症的吸附剂聚合物的施用
MX2012011022A (es) 2010-03-24 2013-02-26 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
ES2717469T3 (es) 2012-08-15 2019-06-21 Tris Pharma Inc Comprimido masticable de metilfenidato de liberación prolongada
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
KR20210094513A (ko) 2018-11-19 2021-07-29 재즈 파마슈티칼즈 아일랜드 리미티드 알코올-내성 약물 제형
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
FI49600C (fi) * 1967-12-20 1975-08-11 Ciba Geigy Ag Menetelmä substituoitujen fenyylietikkahappojen ja näiden suolojen val mistamiseksi.
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
IT8447527A0 (it) 1984-01-10
NZ206815A (en) 1986-08-08
IL70660A (en) 1987-08-31
FI840069A (fi) 1984-07-13
JPS59134759A (ja) 1984-08-02
MA20000A1 (fr) 1984-10-01
FI82682B (fi) 1990-12-31
MC1564A1 (fr) 1984-11-12
ES528770A0 (es) 1985-05-01
AU570230B2 (en) 1988-03-10
LU85171A1 (de) 1984-10-24
NO162862C (no) 1990-02-28
DZ593A1 (fr) 2004-09-13
NL8400098A (nl) 1984-08-01
PL245656A1 (en) 1985-01-02
EP0122219B1 (de) 1988-09-21
EP0122219A2 (de) 1984-10-17
HUT34151A (en) 1985-02-28
ATA784A (de) 1990-04-15
IT1177501B (it) 1987-08-26
ATE37378T1 (de) 1988-10-15
JPH0257058B2 (es) 1990-12-03
EP0122219A3 (en) 1985-05-08
DE3400491C2 (es) 1988-11-10
SE8400098L (sv) 1984-07-13
DD218373A5 (de) 1985-02-06
DE3474152D1 (en) 1988-10-27
CS269954B2 (en) 1990-05-14
HK90390A (en) 1990-11-09
KR900006747B1 (ko) 1990-09-20
PH21795A (en) 1988-02-29
GB2134529A (en) 1984-08-15
ZW484A1 (en) 1984-08-08
PT77932A (en) 1984-02-01
DK11884A (da) 1984-07-13
FI840069A0 (fi) 1984-01-09
DK11884D0 (da) 1984-01-11
AR240310A1 (es) 1990-03-30
CH655507B (es) 1986-04-30
HU190750B (en) 1986-10-28
ZA84212B (en) 1984-08-29
NO840090L (no) 1984-07-13
FR2542735A1 (fr) 1984-09-21
OA07628A (fr) 1985-05-23
AT391467B (de) 1990-10-10
BE898649A (fr) 1984-07-11
CA1218077A (en) 1987-02-17
DK166683B1 (da) 1993-06-28
GR79793B (es) 1984-10-31
PL142737B1 (en) 1987-11-30
NO162862B (no) 1989-11-20
ES8504849A1 (es) 1985-05-01
AU2323084A (en) 1984-07-19
IE840049L (en) 1984-07-12
FI82682C (fi) 1991-04-10
RO88481A (ro) 1986-01-30
GB2134529B (en) 1986-09-24
MTP943B (en) 1984-06-05
SE8400098D0 (sv) 1984-01-10
CS17884A2 (en) 1989-10-13
DE3400491A1 (de) 1984-07-12
IL70660A0 (en) 1984-04-30
GB8400251D0 (en) 1984-02-08
FR2542735B1 (fr) 1986-04-18
US4510128A (en) 1985-04-09
IE56545B1 (en) 1991-08-28
EG16562A (en) 1991-12-30
PT77932B (en) 1986-07-22
KR840007562A (ko) 1984-12-08

Similar Documents

Publication Publication Date Title
SE457959B (sv) Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta
EP0368682B1 (en) Pharmaceutical ion exchange resin composition
DD298049A5 (de) Doppelt beschichtete granulate
JPS63258406A (ja) 持続放出製剤
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
EP0566535B1 (de) Methandiphosphonsäure-Formulierungen mit Ionenaustauschern
IE60209B1 (en) Ion exchange resins loaded with quinolonecarboxylic acid derivatives, their preparation and use
JPS63501684A (ja) こぶ胃で安定なペレット
CN105997891A (zh) 一种替比培南酯制剂及其制备方法
GB1601521A (en) Copolymers of methyl methacrylate and nitrogen-containing acrylate or methacrylate esters
EP0413533A1 (en) Microencapsulated taste-masked water-insoluble NSAID drug materials
CA1038758A (en) High-dosage tablets of cephalosporine derivatives and process for preparing them
CN110974787A (zh) 泊沙康唑干混悬剂及其制备方法
US4369175A (en) Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them
CN101961337A (zh) 一种以阿昔洛韦钠为活性成分的药用组合物
IE51517B1 (en) Drug combination for the treatment of infectious diseases of the respiratory tract
US3035979A (en) Pharmaceutical composition containing a resin-narcotic compound and a resinantihistamine compound
EP0557064B1 (en) Modified release formulation
EP0253293B1 (de) Neue Guanidiniumasparaginate
JPH0622703A (ja) 塩化コリンを基にした動物飼料添加物
CN104473879A (zh) 一种恩诺沙星微丸及其制备方法
CN112294755A (zh) 含有水难溶性药物的医药组合物
GB2078758A (en) Prolonged Action Vincamine Preparations
GB2184731A (en) Preparation of (-)Eburnamenin-14-(15H)-one-resinates
PL98128B1 (pl) Sposob wytwarzania nowych jedno- lub dwuzasadowych soli glinowych kwasu 2-/3-fenoksyfenylo/-propionowego

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8400098-3

Effective date: 19940810

Format of ref document f/p: F